457 Multicenter phase II study of sequential hormonotherapy with Anastrozol/Exemestane (ARIM-AROM) in metastatic breast disease. Preliminary data of Goim 2107 study
R. Formato, R.V. Iaffaioli, A. Tortoriello, S. Del Prete, A. Pisano, F. Fanelli, G. Ianniello, S. Tafuto, G. ColucciVolume:
1
Year:
2003
Language:
english
DOI:
10.1016/s1359-6349(03)90489-7
File:
PDF, 164 KB
english, 2003